AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENETIC SIGNATURES LTD

0.078

0.000

Volume:216.71K

Turnover:16.70K

Market Cap:17.72M

PE:-1.26

High:0.079

Open:0.079

Low:0.074

Close:0.078

52wk High:0.430

52wk Low:0.051

Shares:227.14M

Float Shares:188.02M

Volume Ratio:0.57

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.062

EPS(LYR):-0.062

ROE:-32.64%

ROA:-17.27%

PB:0.50

PE(LYR):-1.26

Loading ...

Overview Company News Filings

Genetic Signatures - Confirms Had no Prior Knowledge of Proposed Acquisition of Shares Referred to in That Announcement

THOMSON REUTERS

Genetic Signatures - no Substantial Holder Notice Received by Co or Lodged with ASX for Share Acquisition Referred to in Bcal's Announcement

THOMSON REUTERS

BCAL to Acquire Shares in Genetic Signatures

BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln

THOMSON REUTERS

Genetic Signatures Ltd-Change of Company Secretary

THOMSON REUTERS

BRIEF-Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director

Genetic Signatures Ltd-Board Reorganisation

THOMSON REUTERS

Genetic Signatures Ltd - Anne Lockwood to Conclude as Interim Managing Director

THOMSON REUTERS

BRIEF-Genetic Signatures Logs Q3 Sales A$3 Mln

Genetic Signatures Ltd - Q3 FY2026 Sales Were a$3 Mln

THOMSON REUTERS

ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep

The West Australian

BUZZ-Australia's Genetic Signatures extends gain on deal with Danish hospital

BUZZ-Australia's Genetic Signatures jumps on supply agreement with Denmark hospital

BRIEF-Genetic Signatures Signs Danish Supply Agreement

BRIEF-Genetic Signatures Says Restructuring Expected To Result In Up To 30 Redundancies

Genetic Signatures Ltd - Estimates Cost Reduction of a$5 Mln From FY2027

THOMSON REUTERS

Genetic Signatures Ltd - Restructuring Expected to Result in up to 30 Redundancies

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/GSS.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.078,"timestamp":1790835120000,"preClose":0.078,"halted":0,"volume":216711,"delay":0,"changeRate":0,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0617,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-01 16:12:00 AEST","open":0.079,"high":0.079,"low":0.074,"amount":16704,"amplitude":0.064103,"askPrice":0.079,"askSize":44864,"bidPrice":0.07,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.0617,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.078,"openAndCloseTimeList":[[1790812800000,1790834400000]],"volumeRatio":0.5746707941351719,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.078,"auctionPrice":0.078,"auctionVolume":40,"auction":3,"marketStatus":"盘后竞价","timestamp":1790834688392}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-17.27%","roe":"-32.64%","lyrEps":-0.0617,"volumeRatio":0.5746707941351719,"shares":227138828,"dividePrice":0,"high":0.079,"amplitude":0.064103,"preClose":0.078,"low":0.074,"week52Low":0.051,"pbRate":"0.50","psRate":"0.92","week52High":0.43,"institutionHeld":0,"latestPrice":0.078,"committee":-0.635462,"eps":-0.0617,"divideRate":0,"volume":216711,"delay":0,"ttmEps":-0.0617,"open":0.079,"prevYearClose":0.25,"prevWeekClose":0.078,"prevMonthClose":0.078,"prevQuarterClose":0.078,"fiveDayClose":0.078,"twentyDayClose":0.087,"sixtyDayClose":0.068,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648579364","title":"Genetic Signatures - Confirms Had no Prior Knowledge of Proposed Acquisition of Shares Referred to in That Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648579364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648579364?lang=en_us&edition=fundamental","pubTime":"2026-07-02 12:41","pubTimestamp":1782967278,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN433100:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648579348","title":"Genetic Signatures - no Substantial Holder Notice Received by Co or Lodged with ASX for Share Acquisition Referred to in Bcal's Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648579348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648579348?lang=en_us&edition=fundamental","pubTime":"2026-07-02 12:41","pubTimestamp":1782967278,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN433100:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578901","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578901?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:34","pubTimestamp":1782956083,"startTime":"0","endTime":"0","summary":"BRIEF-BCAL To Acquire Shares In Genetic SignaturesJuly 2 (Reuters)-BCAL Diagnostics LtdBDX.AX:BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSSTO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLIONFurther company coverage:BDX.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","GSS.AU","BK7048","BDX.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648852202","title":"BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2648852202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648852202?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:04","pubTimestamp":1782950657,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU","BK7048","GSS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644034239","title":"Genetic Signatures Ltd-Change of Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2644034239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644034239?lang=en_us&edition=fundamental","pubTime":"2026-06-19 06:58","pubTimestamp":1781823508,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUE5Q8XRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633042231","title":"BRIEF-Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2633042231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633042231?lang=en_us&edition=fundamental","pubTime":"2026-05-08 09:26","pubTimestamp":1778203579,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing DirectorMay 8 (Reuters) - Genetic Signatures Ltd GSS.AX:BOARD REORGANISATIONANNE LOCKWOOD TO CONCLUDE AS INTERIM MANAGING DIRECTORFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUE4WPBZ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633710368","title":"Genetic Signatures Ltd-Board Reorganisation","url":"https://stock-news.laohu8.com/highlight/detail?id=2633710368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633710368?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:17","pubTimestamp":1778192249,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUE4WPBZ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633103680","title":"Genetic Signatures Ltd - Anne Lockwood to Conclude as Interim Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2633103680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633103680?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:17","pubTimestamp":1778192249,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUE4WPBZ8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631565235","title":"BRIEF-Genetic Signatures Logs Q3 Sales A$3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631565235","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631565235?lang=en_us&edition=fundamental","pubTime":"2026-04-29 09:25","pubTimestamp":1777425939,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Logs Q3 Sales A$3 MlnApril 29 (Reuters) - Genetic Signatures Ltd GSS.AX:Q3 FY2026 SALES WERE A$3 MILLIONFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631532527","title":"Genetic Signatures Ltd - Q3 FY2026 Sales Were a$3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631532527?lang=en_us&edition=fundamental","pubTime":"2026-04-29 06:23","pubTimestamp":1777415004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628278514","title":"ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep","url":"https://stock-news.laohu8.com/highlight/detail?id=2628278514","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628278514?lang=en_us&edition=fundamental","pubTime":"2026-04-17 06:27","pubTimestamp":1776378463,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Bison Resources, which exploded on debut, as punters piled into its prime Nevada gold-silver projects amid ongoing fuel security chaos.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22156398/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22156398/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-bison-genetic-signatures-narryer-immutep-c-22156398","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-bison-genetic-signatures-narryer-immutep-c-22156398","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["DZZ","BTGD","CEF","DUST","PHYS","DULL","BK7508","GSS.AU","IAUM","NYM.AU","OUNZ","DBC","GLTR","BK7048","GBUG","GDXU","GLL","BK4535","GDXY","UGL","AAAU","JDST","GDXD","BK4588","BSR.AU","IAU","BK7067","GOLY","DGP","BK7501","GDX","GDXJ","GLDM","IMM.AU","XME","SGOL","PICK","BK4183","USG","BK7095","ODD","BK4585","BK7104","IE0009354923.USD","RING","FGDL","BEGS","IAUI","JNUG","BAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627126616","title":"BUZZ-Australia's Genetic Signatures extends gain on deal with Danish hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2627126616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627126616?lang=en_us&edition=fundamental","pubTime":"2026-04-16 13:26","pubTimestamp":1776317193,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures extends gain on deal with Danish hospital** Shares of molecular diagnostics firm Genetic Signatures GSS.AX rise 7.1% to A$0.15, their highest level since Feb 6** St","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nL4N40Z0E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472392","title":"BUZZ-Australia's Genetic Signatures jumps on supply agreement with Denmark hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472392","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627472392?lang=en_us&edition=fundamental","pubTime":"2026-04-15 11:31","pubTimestamp":1776223868,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures jumps on supply agreement with Denmark hospital** Shares of Genetic Signatures GSS.AX rise as much as 23.5% to A$0.1, their highest level since March 6** Logs steepest intraday pct rise since March 2** The molecular diagnostics firm signs agreements for the supply of equipment, reagents and consumables for gastrointestinal screening at Hvidovre Hospital in Denmark** About 638,000 shares change hands, 1.6 times the 30-day avg** Down 60.4% YTD, including the session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL6N40Y089:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","GSS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627785473","title":"BRIEF-Genetic Signatures Signs Danish Supply Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627785473","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627785473?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:32","pubTimestamp":1776213132,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Signs Danish Supply AgreementApril 15 (Reuters) - Genetic Signatures Ltd GSS.AX:GENETIC SIGNATURES SIGNS DANISH SUPPLY AGREEMENTFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40X16R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623647813","title":"BRIEF-Genetic Signatures Says Restructuring Expected To Result In Up To 30 Redundancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623647813","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623647813?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:40","pubTimestamp":1774834844,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Says Restructuring Expected To Result In Up To 30 RedundanciesMarch 30 (Reuters) - Genetic Signatures Ltd GSS.AX:GENETIC SIGNATURES ORGANISATIONAL RESTRUCTURERESTRUCTURING EXP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUE1MP7RK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623736317","title":"Genetic Signatures Ltd - Estimates Cost Reduction of a$5 Mln From FY2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2623736317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623736317?lang=en_us&edition=fundamental","pubTime":"2026-03-30 06:08","pubTimestamp":1774822088,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260329:nTUE1MP7RK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623363174","title":"Genetic Signatures Ltd - Restructuring Expected to Result in up to 30 Redundancies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623363174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623363174?lang=en_us&edition=fundamental","pubTime":"2026-03-30 06:08","pubTimestamp":1774822088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260329:nTUE1MP7RK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}